Alpha 2.0
Login Register
» Authors » Laetitia Lacroix

Laetitia Lacroix

Explore the profile of Laetitia Lacroix including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 3993
Followers 0
Related Specialties
Oncology
Biology
Hematology
Top 10 Co-Authors
Catherine Sautes-Fridman
Wolf H Fridman
Florent Petitprez
Etienne Becht
Nicolas A Giraldo
Aurelien De Reynies
Janick Selves
Benedicte Buttard
Julien Calderaro
Wolf Herman Fridman
Published In
Clin Cancer Res
Genome Biol
Cancer Immunol Immunother
Cancer Immunol Res
Methods Mol Biol
Affiliations
Soon will be listed here.
Recent Articles
11.
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
Weinstein A, Giraldo N, Petitprez F, Julie C, Lacroix L, Peschaud F, et al.
Cancer Immunol Immunother . 2018 Oct; 68(1):109-120. PMID: 30315348
IL-1 family cytokines play a dual role in the gut, with different family members contributing either protective or pathogenic effects. IL-36γ is an IL-1 family cytokine involved in polarizing type-1...
12.
PD-L1 Expression and CD8 T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer
Petitprez F, Fossati N, Vano Y, Freschi M, Becht E, Luciano R, et al.
Eur Urol Focus . 2017 Jul; 5(2):192-196. PMID: 28753812
Prostate cancer (PCa) patients with lymph node invasion at radical prostatectomy are at higher risk of tumor recurrence and receive immediate androgen deprivation therapy (ADT). While approximately 30% of these...
13.
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
Giraldo N, Becht E, Vano Y, Petitprez F, Lacroix L, Validire P, et al.
Clin Cancer Res . 2017 Feb; 23(15):4416-4428. PMID: 28213366
The efficacy of PD-1 checkpoint blockade as adjuvant therapy in localized clear cell renal cell carcinoma (ccRCC) is currently unknown. The identification of tumor microenvironment (TME) prognostic biomarkers in this...
14.
Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al.
Genome Biol . 2016 Dec; 17(1):249. PMID: 27908289
No abstract available.
15.
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al.
Genome Biol . 2016 Oct; 17(1):218. PMID: 27765066
We introduce the Microenvironment Cell Populations-counter (MCP-counter) method, which allows the robust quantification of the absolute abundance of eight immune and two stromal cell populations in heterogeneous tissues from transcriptomic...
16.
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Becht E, De Reynies A, Giraldo N, Pilati C, Buttard B, Lacroix L, et al.
Clin Cancer Res . 2016 Mar; 22(16):4057-66. PMID: 26994146
Purpose: The tumor microenvironment is formed by many distinct and interacting cell populations, and its composition may predict patients' prognosis and response to therapies. Colorectal cancer is a heterogeneous disease...
17.
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Giraldo N, Becht E, Pages F, Skliris G, Verkarre V, Vano Y, et al.
Clin Cancer Res . 2015 Feb; 21(13):3031-40. PMID: 25688160
Purpose: Clear cell renal cell carcinoma (ccRCC) has shown durable responses to checkpoint blockade therapies. However, important gaps persist in the understanding of its immune microenvironment. This study aims to...